Atopic dermatitis, also known as eczema, is a chronic, inflammatory skin condition characterized by intense itching, dry skin, and recurrent flare-ups of red, inflamed lesions. It is driven by a ...
Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So first and foremost, moderate to severe ...
Chronic and highly burdensome, atopic dermatitis affects an estimated 223 million people worldwide, with onset commonly ...
AMSTERDAM, Netherlands — For patients with atopic dermatitis (AD) who responded to the anti-interleukin (IL)-13 monoclonal antibody lebrikizumab in the pivotal trials, the level of response, including ...
Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies in effectively managing mild to moderate cases, delaying the need for costly ...
PARIS — For inflammatory dermatological diseases, the phenomenon of a “super response” to a biologic, meaning a rapid and near complete relief of symptoms and disease activity, predicts a higher ...
Adults with atopic dermatitis and chronic hand eczema saw early and sustained improvements in skin and quality of life ...
Major depressive disorder is linked to Th2 immune dysregulation similar to atopic dermatitis. Could dupilumab offer a new therapy? Read more.
Patients with darker skin tones often present because of problems with loss of pigmentation as a result of their atopic dermatitis. Nonetheless, says Megan Rogge, MD, Associate Professor of ...
—A study conducted by a pair of researchers in New York City analyzed vaccination rates among patients on biologics being treated for alopecia areata, atopic dermatitis, psoriasis, and psoriatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results